Paper28073159
Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
Yue X and 16 others. Hepatology, 2017. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Papers, record 28073159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28073159
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Liver Neoplasms | Major topic |
| Receptors, Polymeric Immunoglobulin | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Disease Progression | |
| Dogs | |
| Heterografts | |
| Humans | |
| Neoplasms, Experimental | |
| Proto-Oncogene Mas | |
| Random Allocation | |
| Reference Values |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 32200570 | Correction. | https://conductscience.org/library/papers/32200570 | PubMed |
| Comment in | 29531947 | A novel role for polymeric immunoglobulin receptor in tumour development: beyond mucosal immunity and into hepatic cancer cell transformation. | https://conductscience.org/library/papers/29531947 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42037775 | Analysis of plasma exosomal differential proteins and bioinformatics in intrahepatic cholestasis of pregnancy. | Front Glob Womens Health | 2026 | https://conductscience.org/library/papers/42037775 | PubMed |
| 42010022 | A naturally synonymous mutation modulates an ERK-centered regulatory network to mediate thermotolerance divergence in Crassostrea oysters. | Commun Biol | 2026 | https://conductscience.org/library/papers/42010022 | PubMed |
| 40938415 | Biomarker discovery for lung adenocarcinoma diagnosis using liquid chromatography-mass spectrometry-based enhanced pseudotargeted metabolomics. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/40938415 | PubMed |
| 40442365 | Construction and validation of antibody dependent cell phagocytosis related risk model in breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40442365 | PubMed |
| 40415061 | Polymeric immunoglobulin receptor (pIgR) in cancer progression: a critical role and potential therapeutic target. | Apoptosis | 2025 | https://conductscience.org/library/papers/40415061 | PubMed |
| 40386563 | PIGR predicts good clinical outcomes and plays a tumor suppressor role in the development of breast cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/40386563 | PubMed |
| 39968132 | LINC00870 promotes imatinib resistance in gastrointestinal stromal tumor via inhibiting PIGR glycosylation modifications. | Heliyon | 2025 | https://conductscience.org/library/papers/39968132 | PubMed |
| 39770537 | Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39770537 | PubMed |
| 39388305 | DNA methylation-driven gene FAM3D promotes colorectal cancer growth via the ATF4-SESN2-mTORC1 pathway. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/39388305 | PubMed |
| 39202022 | Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia. | J Pers Med | 2024 | https://conductscience.org/library/papers/39202022 | PubMed |
| 38549127 | Low TYROBP expression predicts poor prognosis in multiple myeloma. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38549127 | PubMed |
| 37789066 | Expression of polymeric immunoglobulin receptor (PIGR) and the effect of PIGR overexpression on breast cancer cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37789066 | PubMed |
| 37006626 | Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37006626 | PubMed |
| 36769200 | Cytoprotective Effects of Human Platelet Lysate during the Xeno-Free Culture of Human Donor Corneas. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769200 | PubMed |
| 36712886 | Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion. | Front Genet | 2022 | https://conductscience.org/library/papers/36712886 | PubMed |
| 36527759 | Neglected no more: B cell-mediated anti-tumor immunity. | Semin Immunol | 2023 | https://conductscience.org/library/papers/36527759 | PubMed |
| 36247154 | Differential plasma proteomes of the patients with Opisthorchiasis viverrini and cholangiocarcinoma identify a polymeric immunoglobulin receptor as a potential biomarker. | Heliyon | 2022 | https://conductscience.org/library/papers/36247154 | PubMed |
| 36012106 | Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012106 | PubMed |
| 35992840 | Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression. | Front Oncol | 2022 | https://conductscience.org/library/papers/35992840 | PubMed |
| 35121863 | Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. | Nat Cancer | 2021 | https://conductscience.org/library/papers/35121863 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDC42 | 998 | PubTator's text mining | https://conductscience.org/library/genes/998 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PIGR | 5284 | PubTator's text mining | https://conductscience.org/library/genes/5284 | NCBI Gene |
| RAC1 | 5879 | PubTator's text mining | https://conductscience.org/library/genes/5879 | NCBI Gene |
| SYK | 6850 | PubTator's text mining | https://conductscience.org/library/genes/6850 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28073159
GET https://conductscience.org/api/papers/v1/28073159/cited_by?page=2